Crowd-Funding is Coming, But Will it Be Niche Only?

If H.R. 1070 is the capital formation bill likely to have the most immediate impact on biotech by providing an IPO alternative for small companies, then H.R. 2930 – which would let private firms raise up to $2 million through crowd-funding – might have the most long-term impact by helping start-ups bridge the valley of death.